Trial NCT04616586

View at ClinicalTrials.gov 
Org. Study IDs: EUSA SYL 0004

Last trial update was posted on 2021-04-19

MeSH Interventions

Siltuximab

MeSH Conditions

Acute Lung Injury Lung Diseases Respiratory Distress Syndrome Respiratory Distress Syndrome, Newborn Respiratory Tract Diseases Respiratory Tract Infections Syndrome

Other Conditions

Acute Respiratory Distress Syndrome Pneumonia Respiratory Tract Disease

Stopping Reasons

The REMAP-CAP and RECOVERY substudy results appear to support the survival benefit of tocilizumab in corticosteroid-treated or untreated patients with critically ill COVID-19-associated ARDS.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID